Wordt geladen...
Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
Despite the success of imatinib mesylate (IM) in the early chronic phase of chronic myeloid leukemia (CML), patients are resistant to IM and other kinase inhibitors in the later stages of CML. Our findings indicate that inhibition of Janus kinase 2 (Jak2) in Bcr–Abl+ cells overcomes IM resistance al...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3072513/ https://ncbi.nlm.nih.gov/pubmed/21183952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2010.287 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|